NXL · Nexalin Technology Inc. Common Stock
View on chartInsiders & Stakes
| Leonard Osser Director | ▲ Buy | Grant | 1,618,577 Shares held | 9/29/2025 | View profile |
| Marilyn Elson Ms. Elson serves as CFO | ▲ Buy | Grant | 1,535,244 Shares held | 9/23/2024 | View profile |
| Ben Hu Director | ▲ Buy | Grant | 377,095 Shares held | 9/29/2025 | View profile |
| Mark White President/CEO | ▲ Buy | Open Market | 289,627 Shares held | 9/16/2022 | View profile |
| David Owens Chief Medical Officer | ▲ Buy | Grant | 191,252 Shares held | 9/29/2025 | View profile |
| Alan Kazden Director | ▲ Buy | Grant | 119,590 Shares held | 9/29/2025 | View profile |
| Rick Morad Director | ▲ Buy | Open Market | 107,989 Shares held | 9/16/2022 | View profile |
| Leslie Bernhard Director | ▲ Buy | Grant | 49,838 Shares held | 9/30/2024 | View profile |
| Carolyn Hamby Shelton Sr. VP - Quality, Regulatory | ▲ Buy | Open Market | 30,000 Shares held | 3/12/2025 | View profile |
Transaction History
| Leonard Osser | ▲ Buy | Grant | 83,333 | $0 | 9/29/2025 |
| David Owens | ▲ Buy | Grant | 36,459 | $0 | 9/29/2025 |
| Ben Hu | ▲ Buy | Grant | 36,459 | $0 | 9/29/2025 |
| Alan Kazden | ▲ Buy | Grant | 36,459 | $0 | 9/29/2025 |
| Carolyn Hamby Shelton | ▲ Buy | Open Market | 6,000 | $13K | 3/12/2025 |
| David Owens | ▲ Buy | Open Market | 1,000 | $3K | 2/4/2025 |
| David Owens | ▲ Buy | Open Market | 1,000 | $3K | 2/4/2025 |
| David Owens | ▲ Buy | Open Market | 1,500 | $4K | 1/28/2025 |
| David Owens | ▲ Buy | Open Market | 1,000 | $3K | 1/23/2025 |
| David Owens | ▲ Buy | Open Market | 2,000 | $5K | 1/13/2025 |
| David Owens | ▲ Buy | Open Market | 500 | $1K | 10/28/2024 |
| Leslie Bernhard | ▲ Buy | Grant | 49,838 | $0 | 9/30/2024 |
| Ben Hu | ▲ Buy | Grant | 175,000 | $0 | 9/30/2024 |
| Marilyn Elson | ▲ Buy | Grant | 700,000 | $0 | 9/23/2024 |
| David Owens | ▲ Buy | Open Market | 1,000 | $950 | 8/13/2024 |
| David Owens | ▲ Buy | Open Market | 1,000 | $2K | 6/28/2024 |
| David Owens | ▲ Buy | Open Market | 1,619 | $1K | 6/18/2024 |
| David Owens | ▲ Buy | Open Market | 1,000 | $620 | 6/10/2024 |
| David Owens | ▲ Buy | Open Market | 2,000 | $1K | 6/10/2024 |
| Marilyn Elson | ▲ Buy | Open Market | 9,500 | $11K | 9/28/2022 |
| Marilyn Elson | ▲ Buy | Open Market | 36,000 | $149K | 9/16/2022 |
| Rick Morad | ▲ Buy | Open Market | 2,500 | $10K | 9/16/2022 |
| Alan Kazden | ▲ Buy | Open Market | 2,500 | $10K | 9/16/2022 |
| David Owens | ▲ Buy | Open Market | 2,500 | $10K | 9/16/2022 |
| Mark White | ▲ Buy | Open Market | 2,500 | $10K | 9/16/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
NXL Listed Among Stocks With Notable Price Movement
Nexalin Technology shares appeared in several daily market lists tracking top gainers and notable movers. The stock is currently flagged with a high beta signal, indicating it tends to move more sharply than the broader market. While specific company news was not provided, its inclusion in these lists highlights recent volatility in trading activity.
NXL Listed Among Stocks With Notable Price Movement. Nexalin Technology shares appeared in several daily market lists tracking top gainers and notable movers. The stock is currently flagged with a high beta signal, indicating it tends to move more sharply than the broader market. While specific company news was not provided, its inclusion in these lists highlights recent volatility in trading activity.